With the release by Acadia of the positive top-line phase 3 drug trial test results for Trofinetide on 2021-12-07, NEU MC rose strongly and maintained a high close at the end of month.
MC (not SP) is always a better comparative parameter to assess NEU against its peers. LTHs who maintained their share of issued capital during CRs should be in the black.
- Forums
- ASX - By Stock
- NEU
- Market Capitalisation is a Better Valuation Metric Than Share Price
Market Capitalisation is a Better Valuation Metric Than Share Price, page-5
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$13.70 |
Change
-0.370(2.63%) |
Mkt cap ! $1.746B |
Open | High | Low | Value | Volume |
$13.73 | $13.88 | $13.40 | $3.470M | 253.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 351 | $13.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.72 | 129 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 644 | 13.680 |
4 | 394 | 13.670 |
4 | 400 | 13.660 |
4 | 489 | 13.650 |
4 | 576 | 13.640 |
Price($) | Vol. | No. |
---|---|---|
13.690 | 312 | 10 |
13.700 | 326 | 6 |
13.710 | 808 | 8 |
13.720 | 1614 | 5 |
13.730 | 770 | 3 |
Last trade - 11.36am 04/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |